A Six-Gene Signature Predicts Clinical Outcome of Gastric Adenocarcinoma

Author:

Li YaQi1,Yu Qi2,Zhu Rui1,Wang Yi1,Li Jiarui3,Wang Qiang4,Guo Wenna4,Fu Shen2,Zhu Liucun1

Affiliation:

1. School of Life Sciences, Shanghai University, Shanghai 200444, China

2. Department of Radiation Oncology, Fudan University Shanghai Cancer Center, Shanghai 200032, China

3. Department of Molecular Biology and Biochemistry, Simon Fraser University, British Columbia, Canada

4. State Key Laboratory of Pharmaceutical Biotechnology, School of Life Sciences, Nanjing University, Nanjing 210093, China

Abstract

Background: The diverse anticancer measures display varied efficacy in different patients. Thus, appropriate therapy should be chosen for individual patients, and prognostic prediction, based on biomarkers, is a prerequisite for personalized therapy. Objective: In this study, the prognostic model was established based on the genes that were significantly correlated with the survival time for patient death risk evaluation. Method: Univariate Cox proportional hazards regression analysis was utilized for screening the genes significantly correlated with the patients’ survival time. Multivariate Cox proportional hazards regression analysis was utilized for establishing the model. Kaplan-Meier and ROC analyses were used for the validation of the prognostic prediction potential of the constructed model. Results: ROC analysis was conducted in the training and validation datasets, and their AUROC values were 0.774 and 0.723, respectively. In comparison to the known prognostic biomarkers, our prognostic biomarker model constituted by the combination of 6 genes displayed superiority in prediction capability. Conclusions: These results indicated that our biomarker model could effectively stratify the risks in gastric adenocarcinoma patients with high prognostic prediction accuracy and sensitivity.

Publisher

Bentham Science Publishers Ltd.

Subject

Organic Chemistry,Computer Science Applications,Drug Discovery,General Medicine

Cited by 3 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3